(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MACRILEN (MACIMORELIN) GRANULES

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

MACRILEN (MACIMORELIN) GRANULES

ST13

US500000079413448

Class

5, 42, 44

Filing

79413448

Registration

8112789

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

34

Latest update

08/05/2026

Trademark type

Combined

Nice classes

5, 42, 44

Filing date

12/03/2024

Registration date

01/27/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/27/2026

Last transaction

08/05/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

16

Owner location

DE

Examiner

OPUTA, CHIOMA N

Law office

L30

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the wording "MACRILEN", in blue, with a triangular design, composed of three blue, green and red curved triangle like shapes, to the left of the wording. Below "MACRILEN" is the wording "(MACIMORELIN) GRANULES" in grey. The white in the mark represents background and is not claimed as a feature of the mark.

Holders and representatives

Holders

AEterna Zentaris GmbH

Representatives

Jacqueline Brousseau Greenberg Traurig, LLP

Technical classification

Nice Classes

Class 5Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Diagnostic preparations for medical usediagnostic preparations for identifying and detecting growth hormone deficiency

Class 42

Scientific and technological servicesresearch and design in the field of medicine and diagnostics

Class 44

Medical and veterinary servicesin particular for the diagnosis of growth hormone deficiency.

Publications

History of USPTO decisions and trademark events.

34 publications found

FICS

FINAL DISPOSITION NOTICE SENT TO IB

08/05/2026

FIMP

FINAL DISPOSITION PROCESSED

08/05/2026

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

06/11/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

05/25/2026

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

05/25/2026

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

04/27/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/27/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

01/27/2026

GPNX

NOTIFICATION PROCESSED BY IB

12/11/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/09/2025

PUBO

PUBLISHED FOR OPPOSITION

12/09/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/03/2025

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

11/26/2025

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

11/25/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/13/2025

XAEC

EXAMINER'S AMENDMENT ENTERED

11/13/2025

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

11/13/2025

GNEA

EXAMINERS AMENDMENT E-MAILED

11/13/2025

CNEA

EXAMINERS AMENDMENT -WRITTEN

11/13/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/15/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/15/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/15/2025

RFNT

REFUSAL PROCESSED BY IB

09/27/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

09/11/2025

RFRR

REFUSAL PROCESSED BY MPU

09/11/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

08/02/2025

CNRT

NON-FINAL ACTION WRITTEN

08/01/2025

RFWR

NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW

07/28/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

06/06/2025

CNRT

NON-FINAL ACTION WRITTEN

06/05/2025

DOCK

ASSIGNED TO EXAMINER

05/22/2025

MAFR

APPLICATION FILING RECEIPT MAILED

12/31/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/31/2024

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

12/26/2024

Continuous trademark protection

Get notified about every new filing that threatens MACRILEN (MACIMORELIN) GRANULES or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.